Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark S. Hertzberg
Circulating Cell-Free miR-494 and miR-21 Are Disease Response Biomarkers Associated With Interim-Positron Emission Tomography Response in Patients With Diffuse Large B-Cell Lymphoma
Oncotarget
Oncology
Related publications
Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Prognostic Value of Interim Positron Emission Tomography in Patients With Peripheral T-Cell Lymphoma
Oncologist
Cancer Research
Medicine
Oncology
Metabolic Tumor Volume Changes Assessed by Interval 18fluorodeoxyglucose Positron Emission Tomography‑computed Tomography for the Prediction of Complete Response and Survival in Patients With Diffuse Large B‑cell Lymphoma
Oncology Letters
Cancer Research
Oncology
Primary Gastric Diffuse Large B-Cell Lymphoma With Orbital Involvement: Diagnostic Usefulness of 18f-Fluorodeoxyglucose Positron Emission Tomography
Internal Medicine
Internal Medicine
Medicine
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Serum Biomarkers Are Associated With Treatment Response in Relapsed Mantle Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Blistering Disease Associated With Diffuse Large B-Cell Lymphoma but Without Autoantibodies
Journal of Dermatology
Dermatology
Medicine
miR-101 Regulates Cell Proliferation and Apoptosis by Targeting KDM1A in Diffuse Large B Cell Lymphoma
Cancer Management and Research
Oncology
Clinical and Hematological Predictors of Response to First-Line Therapy in Patients With Diffuse Large B-Cell Lymphoma
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
